Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.

Robinson RP, Reiter LA, Barth WE, Campeta AM, Cooper K, Cronin BJ, Destito R, Donahue KM, Falkner FC, Fiese EF, Johnson DL, Kuperman AV, Liston TE, Malloy D, Martin JJ, Mitchell DY, Rusek FW, Shamblin SL, Wright CF.

J Med Chem. 2018 Apr 12;61(7):3237. doi: 10.1021/acs.jmedchem.8b00306. Epub 2018 Mar 28. No abstract available.

PMID:
29589934
2.

Development of a new permeability assay using low-efflux MDCKII cells.

Di L, Whitney-Pickett C, Umland JP, Zhang H, Zhang X, Gebhard DF, Lai Y, Federico JJ 3rd, Davidson RE, Smith R, Reyner EL, Lee C, Feng B, Rotter C, Varma MV, Kempshall S, Fenner K, El-Kattan AF, Liston TE, Troutman MD.

J Pharm Sci. 2011 Nov;100(11):4974-85. doi: 10.1002/jps.22674. Epub 2011 Jul 15.

PMID:
21766308
3.

Species independence in brain tissue binding using brain homogenates.

Di L, Umland JP, Chang G, Huang Y, Lin Z, Scott DO, Troutman MD, Liston TE.

Drug Metab Dispos. 2011 Jul;39(7):1270-7. doi: 10.1124/dmd.111.038778. Epub 2011 Apr 7.

PMID:
21474681
4.

Perspectives on bioanalytical mass spectrometry and automation in drug discovery.

Janiszewski JS, Liston TE, Cole MJ.

Curr Drug Metab. 2008 Nov;9(9):986-94. Review.

PMID:
18991596
5.

High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.

Hop CE, Cole MJ, Davidson RE, Duignan DB, Federico J, Janiszewski JS, Jenkins K, Krueger S, Lebowitz R, Liston TE, Mitchell W, Snyder M, Steyn SJ, Soglia JR, Taylor C, Troutman MD, Umland J, West M, Whalen KM, Zelesky V, Zhao SX.

Curr Drug Metab. 2008 Nov;9(9):847-53. Review.

PMID:
18991580
7.

A high-capacity LC/MS system for the bioanalysis of samples generated from plate-based metabolic screening.

Janiszewski JS, Rogers KJ, Whalen KM, Cole MJ, Liston TE, Duchoslav E, Fouda HG.

Anal Chem. 2001 Apr 1;73(7):1495-501.

PMID:
11321300
8.

N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4.

Brown MF, Marfat A, Antognoli G, Chambers RJ, Cheng JB, Damon DB, Liston TE, McGlynn MA, O'Sullivan SP, Owens BS, Pillar JS, Shirley JT, Watson JW.

Bioorg Med Chem Lett. 1998 Sep 22;8(18):2451-6.

PMID:
9873560
9.

Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.

Liston TE, Conklyn MJ, Houser J, Wilner KD, Johnson A, Apseloff G, Whitacre C, Showell HJ.

Br J Clin Pharmacol. 1998 Feb;45(2):115-21.

10.

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P.

J Pharmacol Exp Ther. 1997 Oct;283(1):46-58.

PMID:
9336307
12.

Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.

Teng R, Liston TE, Harris SC.

J Antimicrob Chemother. 1996 May;37(5):955-63.

PMID:
8737145
13.

Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.

Teng R, Girard D, Gootz TD, Foulds G, Liston TE.

Antimicrob Agents Chemother. 1996 Mar;40(3):561-6.

14.

Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography.

Teng R, Tensfeldt TG, Liston TE, Foulds G.

J Chromatogr B Biomed Appl. 1996 Jan 12;675(1):53-9.

PMID:
8634768
15.

Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH group.

Robinson RP, Reiter LA, Barth WE, Campeta AM, Cooper K, Cronin BJ, Destito R, Donahue KM, Falkner FC, Fiese EF, Johnson DL, Kuperman AV, Liston TE, Malloy D, Martin JJ, Mitchell DY, Rusek FW, Shamblin SL, Wright CF.

J Med Chem. 1996 Jan 5;39(1):10-8. Erratum in: J Med Chem. 2018 Apr 12;61(7):3237.

PMID:
8568796
16.

Management of otitis media. A review.

Liston TE.

Clin Pediatr (Phila). 1995 Oct;34(10):542-8. Review. No abstract available.

PMID:
8591682
17.

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.

Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE.

J Antimicrob Chemother. 1995 Aug;36(2):385-94.

PMID:
8522468
18.

Prevention of recurrent otitis media.

Liston TE.

Pediatr Infect Dis J. 1992 Oct;11(10):897-9. No abstract available.

PMID:
1408499
19.

Triacylglycerol lipase activity in the rabbit renal medulla.

Liston TE, Nasjletti A.

Biochim Biophys Acta. 1987 Oct 17;921(3):449-56.

PMID:
2822129
20.

PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings.

Roberts LJ 2nd, Seibert K, Liston TE, Tantengco MV, Robertson RM.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:427-9. No abstract available.

PMID:
2959090
21.

Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer.

Liston TE, Roberts LJ 2nd.

J Biol Chem. 1985 Oct 25;260(24):13172-80.

23.
24.

Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin.

Liston TE, Oates JA, Roberts LJ 2nd.

Adv Prostaglandin Thromboxane Leukot Res. 1985;15:365-7. No abstract available.

PMID:
2936123
25.
26.

Should sputum isolates of Haemophilus influenzae be serotyped?

Liston TE.

South Med J. 1984 Feb;77(2):164-7. Review.

PMID:
6367071
27.

Sulfisoxazole chemoprophylaxis and recurrent otitis media.

Liston TE, Harbison R.

West J Med. 1984 Jan;140(1):47-9.

28.

The bacteriology of recurrent otitis media and the effect of sulfisoxazole chemoprophylaxis.

Liston TE, Foshee WS, McCleskey FK.

Pediatr Infect Dis. 1984 Jan-Feb;3(1):20-4.

PMID:
6366770
29.

Relapsing Neisseria meningitidis infection associated with C8 deficiency.

Liston TE.

Clin Pediatr (Phila). 1983 Sep;22(9):605-7.

PMID:
6411408
30.

Polymicrobial bacteremia due to Polle syndrome: the child abuse variant of Munchausen by proxy.

Liston TE, Levine PL, Anderson C.

Pediatrics. 1983 Aug;72(2):211-3.

PMID:
6866607
31.
32.

Sulfisoxazole chemoprophylaxis for frequent otitis media.

Liston TE, Foshee WS, Pierson WD.

Pediatrics. 1983 Apr;71(4):524-30.

PMID:
6601256
33.

Pneumococcal subcutaneous abscess in immunocompetent children.

Liston TE.

Am J Dis Child. 1982 Oct;136(10):947-8. No abstract available.

PMID:
7124685
34.

Invasive disease due to nontypable Haemophilus influenzae in children.

Liston TE, Foshee WS.

South Med J. 1982 Jun;75(6):753-4.

PMID:
6979799
35.

Orbital aspergillosis: report of a case in a child.

Whitehurst FO, Liston TE.

J Pediatr Ophthalmol Strabismus. 1981 May-Jun;18(3):50-4.

PMID:
7264852
36.

Early diagnosis and management of cerebritis in a child.

Liston TE, Tomasovic JJ, Stevens EA.

Pediatrics. 1980 Mar;65(3):484-6.

PMID:
7360534
37.

Relationship of neonatal pneumonia to maternal urinary and neonatal isolates of group B streptococci.

Liston TE, Harris RE, Foshee S, Null DM Jr.

South Med J. 1979 Nov;72(11):1410-2.

PMID:
388649

Supplemental Content

Loading ...
Support Center